Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 61.74%
June 30, 2026 59.62%
March 31, 2026 57.87%
December 31, 2025 58.51%
September 30, 2025 14.19%
June 30, 2025 52.89%
March 31, 2025 46.83%
December 31, 2024 46.95%
September 30, 2024 48.91%
June 30, 2024 44.49%
March 31, 2024 42.47%
December 31, 2023 36.15%
September 30, 2023 46.37%
June 30, 2023 42.73%
Date Value
March 31, 2023 52.78%
December 31, 2022 46.51%
September 30, 2022 50.25%
June 30, 2022 38.76%
March 31, 2022 37.24%
December 31, 2021 31.21%
September 30, 2021 32.12%
June 30, 2021 46.17%
March 31, 2021 49.12%
December 31, 2020 48.30%
September 30, 2020 50.46%
June 30, 2020 44.11%
March 31, 2020 52.87%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 98.37%
Amgen, Inc. 73.09%
Anika Therapeutics, Inc. 61.57%
BioCryst Pharmaceuticals, Inc. 98.99%
Imunon, Inc. --

Gross Profit Margin (Quarterly) Related Metrics